Exelixis Inc Surpasses Analyst Target Price Amid Varied Ratings
In recent trading, shares of Exelixis Inc (Symbol: EXEL) have exceeded the average analyst 12-month target price of $37.15, currently exchanging hands at $37.21 per share. When a stock reaches its target price as set by analysts, they typically respond in one of two ways: downgrade the valuation or revise the target price upward. Analyst reactions can also vary based on fundamental business developments that may influence the stock’s upward movement—if the company’s outlook is improving, it may warrant a higher target price.
There are currently 20 different analyst targets contributing to the average for Exelixis Inc, but this average itself is merely a statistical representation. Some analysts have set lower price targets, including one projecting a price of $23.00. Conversely, the highest target from an analyst stands at $45.00, with a standard deviation of $5.537.
Investors often consult the average target to engage in a “wisdom of crowds” approach, synthesizing insights from multiple analysts rather than relying on an individual opinion. With EXEL now trading above the average target price of $37.15 per share, investors are encouraged to re-evaluate the company. This raises the question: Is $37.15 merely a stopping point en route to a higher target, or has the stock’s valuation become inflated, prompting a need to reassess holdings? Below is a table outlining the current analyst perspectives on Exelixis Inc:
Recent EXEL Analyst Ratings Breakdown | ||||
---|---|---|---|---|
» | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
Strong buy ratings: | 10 | 11 | 12 | 11 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 9 | 9 | 8 | 9 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 1 | 1 | 1 | 1 |
Average rating: | 2.1 | 2.05 | 1.95 | 2.05 |
The average rating in the last row of the table ranges from 1 to 5, where 1 signifies a Strong Buy and 5 indicates a Strong Sell. This article includes data provided by Zacks Investment Research via Quandl.com.
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.